CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...

NEW YORK CITY -- A form of light therapy led to durable improvement in visual acuity for patients with dry age-related macular degeneration, according to interim results from an ongoing randomized ...

The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic ...

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ...

Please provide your email address to receive an email when new articles are posted on . MCO-010, a mutation-agnostic gene therapy, demonstrated vision improvement in retinitis pigmentosa. Nanoscope ...

Age-related macular degeneration (AMD) is a leading cause of vision loss among people aged 50 and older. While treatments for the wet form of AMD have shown promise, the dry form, which accounts for ...

Hrithik Roshan recently shared that his eye power reduced by nearly half, sparking widespread curiosity. “At 42, my ever-so-proper eye doctor laughed and lovingly said to me: "Haha, no, I am sorry, ...

Eyesight, or vision, is the ability to see. Lifestyle factors such as eating a well-balanced diet, regular physical activity, taking screen breaks, and avoiding smoking can support eye and vision ...

Please provide your email address to receive an email when new articles are posted on . The study investigated Qlosi’s (pilocarpine hydrochloride ophthalmic solution 0.4%, Orasis Pharmaceuticals) ...

The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic ...